The source of comparative advantage in t
โ
Brian F. Lavoie; Ian M. Sheldon
๐
Article
๐
2000
๐
John Wiley and Sons
๐
English
โ 40 KB
๐ 1 views
Sources of heterogeneity within the process of research and development (R&D) investment, such as international differences in the maximum per-period rate of investment and level of regulatory uncertainty, offer a plausible explanation for US comparative advantage in biotechnology. Using dynamic sto